QUARTI TREVANO FOSCA ANNA LUISA

Cuspidi, C., Facchetti, R., Quarti-Trevano, F., Tadic, M., Vanoli, J., Mancia, G., et al. (2026). Targeting the Association between Interarm Blood Pressure Difference and Subclinical Organ Damage: Findings from the PAMELA Study. AMERICAN JOURNAL OF HYPERTENSION, 39(4 (April 2026)), 570-577 [10.1093/ajh/hpaf207]. Detail

Massabò, D., Quarti-Trevano, F., Seravalle, G., Facchetti, R., Dell'Oro, R., Tsioufis, K., et al. (2025). FAILURE OF ANTIHYPERTENSIVE TREATMENT TO RESTORE NORMAL SYMPATHETIC ACTIVITY. JOURNAL OF HYPERTENSION, 43(S1), 214-214 [10.1097/01.hjh.0001117400.59486.c3]. Detail

Russo, E., Viazzi, F., Pontremoli, R., Angeli, F., Barbagallo, C., Berardino, B., et al. (2025). Predictive value of TG/HDL-C and GFR-adjusted uric acid levels on cardiovascular mortality: the URRAH study. LIPIDS IN HEALTH AND DISEASE, 24(1) [10.1186/s12944-025-02440-w]. Detail

Grassi, G., Quarti Trevano, F., Cuspidi, C., Sanidas, E., Mancia, G., Thomopoulos, C. (2025). Sympathetic Overactivation in the Resistant Hypertensive Phenotype: A Meta-Analysis of Published Studies. HYPERTENSION, 82(8), 1346-1354 [10.1161/HYPERTENSIONAHA.125.24749]. Detail

D'Elia, L., Masulli, M., Virdis, A., Casiglia, E., Tikhonoff, V., Angeli, F., et al. (2025). Triglyceride-glucose Index and Mortality in a Large Regional-based Italian Database (Urrah Project). THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 110(2 (1 February 2025)), 470-477 [10.1210/clinem/dgae170]. Detail